prognosis
Pfizer Outlines Booster Plans While Regulators Signal Caution
By and
Updated on
-
Early human data shows third shot raises antibody levels
-
Federal health agencies say no need for boosters at this time
Pfizer Plans to Request FDA Nod for Covid Booster
Pfizer Inc. plans to request U.S. emergency authorization in August for a third booster dose of its Covid-19 vaccine, based on early data showing that it can sharply increase immune protection against the coronavirus.
At the same time, however, federal health officials signaled that they would take a cautious approach to potential booster shots, and underlined that the currently available vaccines are effective at keeping people from being sickened by the coronavirus.
